e-learning
resources
Paris 2018
Monday, 17.09.2018
Clinical aspects of hypersensitivity pneumonitis (HP) and CTD-ILD: diagnosis, monitoring and treatment
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Pirfenidone as a treatment for asbestos-related lung fibrosis? A retrospective case series
F. Rytz (Bern, Switzerland), A. Poellinger (Bern, Switzerland), S. Berezowska (Bern, Switzerland), T. Geiser (Bern, Switzerland), M. Funke-Chambour (Bern, Switzerland)
Source:
International Congress 2018 – Clinical aspects of hypersensitivity pneumonitis (HP) and CTD-ILD: diagnosis, monitoring and treatment
Session:
Clinical aspects of hypersensitivity pneumonitis (HP) and CTD-ILD: diagnosis, monitoring and treatment
Session type:
Thematic Poster
Number:
2993
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
F. Rytz (Bern, Switzerland), A. Poellinger (Bern, Switzerland), S. Berezowska (Bern, Switzerland), T. Geiser (Bern, Switzerland), M. Funke-Chambour (Bern, Switzerland). Pirfenidone as a treatment for asbestos-related lung fibrosis? A retrospective case series. 2993
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
A case series study on re-treatment to lung cancer after drug-induced interstitial lung disease
Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis: from the bench to the bedside
Year: 2018
Lung cancer in combined pulmonary fibrosis and emphysema: a large retrospective cohort analysis
Source: ERJ Open Res, 6 (4) 00521-2020; 10.1183/23120541.00521-2020
Year: 2020
Is lung function worsening during adolescence in cystic fibrosis? A retrospective study
Source: Annual Congress 2012 - Cystic fibrosis (adults and children): new aspects of risk factors, treatments and diagnosis
Year: 2012
A prospective evaluation of lung ultrasonography in patients with fibrotic interstitial lung diseases; preliminary results.
Source: International Congress 2018 – News on the diagnosis of idiopathic interstitial pneumonia
Year: 2018
PROOF-registry: A prospective observational registry to describe the disease course and outcomes of IPF patients in a real-world clinical setting- An interim report
Source: International Congress 2015 – IPF: clinical aspects
Year: 2015
Autopsy findings in 42 consecutive patients with idiopathic pulmonary fibrosis
Source: Eur Respir J 2008; 32: 170-174
Year: 2008
Pirfenidone treatment in idiopathic pulmonary fibrosis: An Italian case series
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view
Year: 2013
Multidisciplinary diagnosis of interstitial lung disease: a retrospective analysis
Source: International Congress 2019 – Medical education
Year: 2019
A prospective evaluation of lung ultrasonography in patients with fibrotic interstitial lung diseases.
Source: Virtual Congress 2021 – News in treatment and diagnosis of idiopathic interstitial pneumonia
Year: 2021
Clarifying the diagnosis of post-inflammatory pulmonary fibrosis: a population-based study
Source: Eur Respir J, 54 (1) 1900103; 10.1183/13993003.00103-2019
Year: 2019
Prospective study of feasibility and safety of bronchoscopic transbronchial cryprobe biopsies in interstitial lung disease: Initial experience of an Irish interstitial lung disease centre
Source: International Congress 2015 – New insights into IIPs
Year: 2015
Longitudinal assessment in combined pulmonary fibrosis and emphysema (CPFE): a case series
Source: Annual Congress 2009 - Pulmonary circulation I
Year: 2009
PROOF: A prospective observational registry to describe the disease course and outcomes of idiopathic pulmonary fibrosis patients in a real-world clinical setting in Belgium and Luxembourg: Exposure in the interim report of 175 IPF patients
Source: International Congress 2016 – IPF clinical
Year: 2016
A retrospective clinical review of drug induced interstitial lung disease at a tertiary cancer centre
Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis: from the bench to the bedside
Year: 2018
Surgical lung biopsy in the diagnosis of idiopathic pulmonary fibrosis: a systematic review
Source: Annual Congress 2009 - Various backgrounds in diffuse parenchymal lung disease
Year: 2009
LATE-BREAKING ABSTRACT: Role of trans-bronchial lung cryobiopsies in interstitial lung diseases: Preliminary results of a Belgian prospective study
Source: International Congress 2016 – IPF clinical
Year: 2016
Pirfenidone in patients with advanced idiopathic pulmonary fibrosis: First experience
Source: International Congress 2016 – IPF: from pathogenesis to treatment I
Year: 2016
PROOF-registry: A prospective observational registry to describe the disease course and outcomes of idiopathic pulmonary fibrosis patients in a real-world clinical setting
Source: International Congress 2014 – ILDs 6
Year: 2014
Prognosis of idiopathic pulmonary fibrosis without anti-fibrotic therapy: a systematic review
Source: Eur Respir Rev, 29 (157) 190158; 10.1183/16000617.0158-2019
Year: 2020
Treatment dilemmas in sarcoidosis - a retrospective cohort study
Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept